Kidney transplant patients accuse SHA of 'punitive' rules that put lives at risk

Kidney transplant recipients have accused the Social Health Authority (SHA) of enforcing benefit rules that they say are putting lives at risk, warning that restrictive funding policies and chronic drug shortages are undermining Kenya's organ transplant programme.

In a petition addressed to the Social Health Authority, the Ministry of Health and other health agencies, the Renal Patients Society of Kenya called for an urgent review of the post-kidney transplant benefits package, arguing that the current system is medically unsound and economically counterproductive.

The patients' lobby says the existing framework governing post-transplant care exposes recipients to interruptions in treatment, increasing the risk of organ rejection despite the government spending more than Sh1 million on each kidney transplant.

At the centre of the dispute is SHA's annual post-transplant benefit of Sh200,000, which patients say is difficult to access because of administrative rules that fail to reflect the realities of long-term transplant care.

"The administrative framework governing its access is fundamentally unscientific, punitive and completely detached from the clinical realities of post-transplant care," said John Gikonyo, President of the Renal Patients Society of Kenya.

The society argues that one of the most damaging restrictions is a rule allowing patients to make only one claim every 30 days, regardless of whether they need laboratory tests, specialist consultations or medication.

According to the society, kidney transplant recipients must undergo routine therapeutic drug monitoring to measure levels of immunosuppressive medicines before doctors can safely adjust prescriptions.

Under the current arrangement, patients who use their monthly benefit for laboratory tests may be unable to collect the medicines they need until the following month.

"Post-transplant care requires patients to routinely undergo critical therapeutic drug monitoring laboratory tests before their prescriptions can be safely adjusted and dispensed.

Because of the single-access rule, a patient cannot run essential laboratory tests and pick up life-saving medication within the same month," the petition states.

The society has also criticised what it describes as the monthly fragmentation of the annual benefit.

Although each patient is allocated Sh200,000 a year, the amount is effectively broken into monthly limits of about Sh16,667, with unused balances reportedly expiring instead of rolling over.

Patients argue that transplant care is unpredictable, with medication needs fluctuating depending on an individual's condition.

"Organ stability fluctuates. A patient may require expensive interventions in one month and much lower costs in another.

Forfeiting unused monthly balances denies patients the healthcare benefits they are paying for," the society said.

The concerns are compounded by persistent shortages of essential immunosuppressive medicines at Kenyatta National Hospital (KNH), one of only two public facilities offering specialised post-transplant care.

According to the petition, stock-outs sometimes force the hospital to dispense only a week's supply of medication, even when patients have prescriptions covering an entire month.

Because the SHA system allows only one access within 30 days, patients say they are unable to return and collect the remaining medicines after supplies are replenished.

"The system locks them out from returning to claim the remaining weeks of their prescription once stocks arrive," Gikonyo said.

The society argues that the situation not only endangers patients but also places a greater financial burden on taxpayers.

It notes that SHA can spend approximately Sh1.1 million on a kidney transplant, only for inadequate post-operative support to increase the likelihood of organ rejection, forcing patients back onto dialysis.

Each dialysis session costs SHA about Sh10,650, making failed transplants significantly more expensive over time than maintaining stable transplant recipients on uninterrupted medication.

"This structural dysfunction does not save the government money; it aggressively wastes public funds," the petition says.

The Renal Patients Society is now demanding immediate reforms, including the removal of the 30-day single-access rule, replacement of the monthly spending cap with a flexible annual benefit, emergency funding to eliminate drug shortages at KNH and an interim administrative waiver to ensure patients continue receiving uninterrupted treatment while broader policy changes are considered.

The group has given SHA and the Ministry of Health seven days to acknowledge the complaint and provide a roadmap outlining how the concerns will be addressed.